NOS3 rs2070744: What Your Genotype Means
The rs2070744 variant is a single nucleotide polymorphism located in the promoter region of the NOS3 gene. It is associated with variations in the production of endothelial nitric oxide, which may influence cardiovascular health and individual responses to certain antihypertensive medications.
What each genotype means
Typical NOS3 promoter activity
This genotype represents the common version of the NOS3 promoter region. Research suggests this version is associated with standard levels of endothelial nitric oxide synthase transcription compared to the C allele. Please note that cardiovascular health is influenced by many genetic and lifestyle factors, and this result does not guarantee any specific health outcome.
This is the most common genotype in many populations, though frequencies vary significantly by ancestry.
Reduced promoter activity potential
Carrying one copy of the C allele may be associated with reduced transcription of the endothelial nitric oxide synthase gene. Some studies have linked the C allele to an increased risk of conditions like essential hypertension or coronary artery spasm, though findings are mixed and often depend on specific population backgrounds. Discuss any concerns regarding cardiovascular health or blood pressure management with your clinician.
This heterozygous genotype is common, appearing in a significant portion of individuals across many global populations.
Increased risk association
Individuals with this genotype carry two copies of the C allele, which has been associated in some research with impaired endothelial nitric oxide synthase transcription. This variant is studied for its potential link to susceptibility for coronary artery spasm and essential hypertension. Because these associations are complex and influenced by environmental factors, please consult with a healthcare provider to discuss your cardiovascular risk profile.
This genotype is less common than the TT or TC combinations in many populations, with frequencies varying by ancestry.
Understanding the rs2070744 Variant
The rs2070744 variant, often referred to in scientific literature as the -786T>C polymorphism, is a change in the DNA sequence within the promoter region of the NOS3 gene. A promoter region acts as a control switch for a gene, determining how much of a specific protein is produced. In this case, the presence of the C allele is frequently studied for its potential to impair the transcription of the NOS3 gene. Because this variant sits in a regulatory area rather than the protein-coding sequence itself, it does not change the structure of the resulting protein, but rather the efficiency with which the body produces it. Researchers have investigated this site extensively to understand how subtle genetic differences in gene regulation can contribute to complex cardiovascular traits.
The Role of the NOS3 Gene
The NOS3 gene provides instructions for making an enzyme called endothelial nitric oxide synthase (eNOS). This enzyme is primarily responsible for producing nitric oxide in the lining of blood vessels, known as the endothelium. Nitric oxide is a critical signaling molecule that helps blood vessels relax and widen, a process called vasodilation. By maintaining healthy vascular tone, nitric oxide helps regulate blood pressure and prevents the formation of blood clots. When eNOS activity is reduced, the ability of blood vessels to dilate may be compromised. Because the rs2070744 variant is located in the promoter, it is hypothesized to influence the total amount of eNOS enzyme available, thereby impacting the body's ability to maintain optimal vascular health and blood pressure regulation.
Research Associations and Evidence Strength
Scientific research has explored the link between rs2070744 and various cardiovascular conditions, including essential hypertension and coronary artery spasm. Some studies suggest that individuals carrying the C allele may have a higher risk of resistant hypertension, a condition where blood pressure remains uncontrolled despite the use of multiple medications. However, the evidence remains mixed and is often context-dependent. For instance, some studies have found significant associations in specific populations, while others have observed no significant differences. Furthermore, the variant has been studied for its potential to influence how patients respond to antihypertensive drugs, such as diuretics or ACE inhibitors. Because cardiovascular health is influenced by a complex interplay of many genes, lifestyle factors, and environmental triggers, the clinical utility of this single variant is currently considered limited. It is not a diagnostic tool, and any questions regarding medication efficacy should be directed to a healthcare professional.
Population Frequency
The frequency of the rs2070744 variant varies significantly across different ancestral groups. In European populations, the minor allele frequency is typically observed between 0.35 and 0.40. In contrast, the variant is less common in East Asian populations, where the minor allele frequency is approximately 0.12. These differences highlight the importance of considering genetic ancestry when interpreting research findings, as the prevalence of specific genotypes can differ widely depending on the population being studied.
What This Information Means for You
Genetic information regarding rs2070744 should be viewed as a piece of a much larger puzzle. While research explores its role in cardiovascular health, it is not a definitive predictor of disease. Many people with the 'higher-attention' genotype live healthy lives, and many without it may still experience cardiovascular issues. You cannot use this information to diagnose yourself or to make independent changes to your medical treatment. If you are concerned about your blood pressure or your response to medication, the most important step is to consult with your doctor or a pharmacist. They can evaluate your clinical history, lifestyle, and other risk factors to provide personalized guidance. Never stop or change your prescribed medications based on genetic test results without professional medical supervision.
How common is this variant?
The minor allele frequency is approximately 0.35-0.40 in European populations and lower in East Asian populations at approximately 0.12.
Frequently asked questions
Is rs2070744 a diagnostic test for heart disease?
No, rs2070744 is not a diagnostic test. It is a genetic variant associated with cardiovascular traits in research studies, but it cannot predict whether an individual will develop heart disease.
Should I change my blood pressure medication based on my genotype?
You should never change your medication based on genetic results. Always consult your doctor or pharmacist before making any adjustments to your prescribed treatment plan.
What does the NOS3 gene do?
The NOS3 gene provides instructions for making the eNOS enzyme, which produces nitric oxide. Nitric oxide helps blood vessels relax and maintain healthy blood pressure.
Why do results for this variant differ between studies?
Genetic associations can be influenced by differences in study design, population ancestry, and environmental factors. This is why the evidence for many variants remains mixed or limited.
Sources & further reading
Educational information only, last refreshed 9/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2070744?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in NOS3
Also known as Glu298Asp (894G>T), this variant affects endothelial nitric oxide synthase cleavage and vascular tone, modulating exercise-induced vasodilation and aerobic performance.
An intronic endothelial nitric oxide synthase polymorphism that influences vascular tone, exercise-induced vasodilation, and aerobic endurance performance.
Endothelial nitric oxide synthase variant implicated in blood flow response and muscle capillarization during aerobic training.
The Glu298Asp variant in the NOS3 gene is associated with altered nitric oxide production and may influence susceptibility to cardiovascular conditions like hypertension and coronary artery disease.
Promoter-adjacent polymorphism affecting endothelial nitric oxide synthase transcription, modulating exercise-induced vasodilation and aerobic trainability.